Molecular Mechanisms of Cancer Drug Resistance: Emerging Biomarkers and Promising Targets to Overcome Tumor Progression
Author:
Abstract
Publisher
MDPI AG
Subject
Cancer Research,Oncology
Link
https://www.mdpi.com/2072-6694/14/7/1614/pdf
Reference39 articles.
1. Cancer statistics, 2022
2. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies
3. A History of Cancer Chemotherapy
4. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
5. Small molecules, big impact: 20 years of targeted therapy in oncology
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. FTO promotes gefitinib-resistance by enhancing PELI3 expression and autophagy in non-small cell lung cancer;Pulmonary Pharmacology & Therapeutics;2024-12
2. Anticancer Properties of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Potential Agonists 4-Thiazolidinone-Pyrazoline Hybrids Les-4368 and Les-4370 in Colorectal Adenocarcinoma Cells In Vitro;Applied Sciences;2024-08-30
3. A Review of the Efficacy of Nanomaterial-Based Natural Photosensitizers to Overcome Multidrug Resistance in Cancer;Pharmaceutics;2024-08-24
4. Lipid Nanoparticular Codelivery System for Enhanced Antitumor Effects by Ferroptosis–Apoptosis Synergistic with Programmed Cell Death-Ligand 1 Downregulation;ACS Nano;2024-06-13
5. RNA epigenetics in pulmonary diseases: Insights into methylation modification of lncRNAs in lung cancer;Biomedicine & Pharmacotherapy;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3